The publication says in market where botox and creams rule, 10-19 year olds have real spending power and are highly brand aware. Being romance seekers, they are not bashful about spending big bucks to make themselves look good.
A new report would help companies prepare for new product launches as it specifically analyses new US White Papers on immunogenicity to bioloigcs and provides regulatory advice on working with the Food and Drug Administration (FDA) and the European Medicines Agency (EMEA).
Authors of a new report say that the excipient chemical market is broken down into applications of organic, inorganic and United States Pharmacopeia (USP) water chemicals. Of these, organic chemicals have the largest share of the market and this segment is expected to be worth $3.7 billion by 2011, a CAGR of 3.8%.
The market is broken down by contaminant type including pathogens, genetically modified organisms (GMOs), toxins, residues and others. Of these, pathogen testing has the largest share of the market. Valued at nearly $1.8 billion in 2007, this segment is expected to be worth $2.4 billion by 2012, a CAGR of 5.1%.
The report says the fastest growing segment is the market for therapeutic devices which is predicted to show a CAGR of 13.4% between 2007 and 2012.
http://www.reportbuyer.com/pharma_healthcare/medical_devices/home_medical_equipment_market.html
Satisfied Users & 
Approved Press Releases
